Prognostic Significance of Laminin, Laminin Receptor, and Bone Marrow Micrometastases in Breast Cancer Patients: Are These Markers of Aggressive Behavior and Metastatic Potential?

Applied Immunohistochemistry and Molecular Morphology

Volumn 11, Issue 4, 2003, Pages 311-318

  Molino, Annamaria ^a,d   Pedersini, Rebecca ^a   Micciolo, Rocco ^b   Frisinghelli, Michela ^a   Giovannini, Monica ^a   Pavarana, Michele ^a   Santo, Antonio ^a   Colato, Chiara ^a   Piubello, Quirino ^c   Cetto, Gian Luigi ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF TRENTO   (Italy)

^c Azienda Ospedaliera   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

Author keywords

Bone marrow; Breast cancer; Laminin; Laminin receptor; Prognostic factors

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; LAMININ; LAMININ RECEPTOR; MEMBRANE PROTEIN; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGE; AGED; BASEMENT MEMBRANE; BONE MARROW METASTASIS; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 0346874337     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200312000-00006     Document Type: Conference Paper

References (46)

1. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 4th ed. Philadelphia, PA: JB Lippincott, 1993:1264-332.
2. Kirk SJ, Cooper GG, Hoper M, et al. The prognostic significance of bone marrow micrometastases in women with early breast cancer. Eur J Surg Oncol. 1990;16:481-5.
3. Dearnaley DP, Ormerod MG, Sloane JP. Micrometastases in breast cancer: long term follow-up of the first patient cohort. Eur J Cancer. 1991;27:236-9.
4. Mansi JL, Easton D, Berger U, et al. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer. 1991;27:1552-5.
5. Molino A, Pelosi G, Turazza M, et al. Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis. Breast Cancer Res Treat. 1997;42:22-30.
6. Molino A, Pelosi G, Micciolo R. Bone marrow micrometastases in breast cancer patients. Breast Cancer Res Treat. 1999;58:123-30.
7. Diel IJ, Kaufmann M, Goerner R, et al. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol. 1992;10:1534-9.
8. Funke I, Schraut W. Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol. 1998;16:557-66.
9. Timpl R, Rohde H, Robey PG, et al. Laminin: a glycoprotein from basement membranes. J Biol Chem. 1979;254:9933-7.
10. Kleinman HK, Cannon FB, Laurie JR, et al. Biological activities of laminin. J Cell Biochem. 1985;27:317-25.
11. Albrechtsen R, Nielsen M, Wewer V, et al. Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res. 1981;41:5076-81.
12. D'Ardenne AJ, Richman PI, Horton MA, et al. Co-ordinate expression of the alpha-6 integrin laminin receptor subunit and laminin in breast cancer. J Pathol. 1991;165:213-20.
13. Barsky SH, Rao CN, Williams JE, et al. Laminin molecular domains which alter metastases in a murine model. J Clin Invest. 1984;74:843-8.
14. Malinoff HL, Mc Coy JP, Varani J, et al. Metastatic potential of murine fibrosarcoma cells is influenced by cell surface laminin. Int J Cancer. 1984;33:651-5.
15. Malinoff HL, Wicha MS. Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells. J Cell Biol. 1983; 96:1475-9.
16. Rao CN, Barsky SH, Terranova VP, et al. Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun. 1983;111:804-8.
17. Lesot H, Kuhl U, Von der Mark K. Isolation of a laminin-binding protein from muscle cell membrane. EMBO J. 1983;2:861-5.
18. Campo E, Monteagudo C, Castronovo V, et al. Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissue by in situ hybridization. Am J Pathol. 1992;141:1073-83.
19. Vacca A, Ribatti D, Roncali L, et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer. 1993;72:455-61.
20. Silvestrini R, Costa A, D'Errico A, et al. Biological markers in hepatocellular carcinoma: potential clinical implication. J Surg Oncol. 1993;3:18-20.
21. Castronovo V, Colin C, Claysmith A, et al. Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. Am J Pathol. 1990; 137:1373-81.
22. Cioce V, Castronovo V, Shmookler BM, et al. Increased expression of the laminin receptor in human colon cancer. J Natl Cancer Inst. 1991;83:29-36.
23. Terranova VP, Rao CN, Kahebic T, et al. Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci U S A. 1983; 80:444-8.
24. Castronovo V, Taraboletti G, Liotta LA, et al. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. J Natl Cancer Inst. 1989;81:781-8.
25. Marques AL, Franco ELF, Torloni H, et al. Independent prognostic value of laminin expression in breast cancer survival. Cancer Res. 1990;50:1479-83.
26. Daidone MG, Silvestrini R, D'Errico A, et al. Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer. 1991;48:529-32.
27. U.I.C.C. International Union Against Cancer. TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumors. Berlin and Heidelberg, Germany: Springer-Verlag, 1992.
28. Molino A, Micciolo R, Turazza M, et al. Estrogen receptors in 699 primary breast cancer: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat. 1995;34:221-8.
29. Gerdes J, Pickartz H, Brotherton J, et al. Growth-fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies. Am J Pathol. 1987;129:486-92.
30. Tagliabue E, Porro G, Barbanti P, et al. Improvement of tumor cell detection using a pool of monoclonal antibodies. Hybridoma. 1986;5:107-15.
31. Molino A, Colombatti M, Bonetti F, et al. A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer. 1991;67:1033-6.
32. Pelosi G, Bresaola E, Manfrin E, et al. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human neoplasm using PC10, reactive with proliferating cell nuclear antigen (PCNA), and KI67: a comparative study. Arch Pathol Lab Med. 1994;118:510-6.
33. Martignone S, Pellegrini R, Villa E, et al. Characterization of two monoclonal antibodies directed against the 67 KD high affinity laminin receptor and application for the study of breast carcinoma progression. Clin Exp Metastasis. 1992;10:379-86.
34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association. 1958;53:457-81.
35. Cox DR. Regression models and life tables (with discussion). Journal of the Royal Statistical Society, Series B (34) 1972:187-220.
36. Stata Corp. STATA statistical software: release 7.0 [computer software]. College Station, TX: Stata Corp, 2001.
37. Pellegrini R, Martignone S, Tagliabue E, et al. Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas. Breast Cancer Res Treat. 1995;35:195-9.
38. Castronovo V, Taraboletti G, Liotta LA, et al. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. J Natl Cancer Inst. 1989;81:781-8.
39. Martignone S, Ménard S, Bufalino R, et al. Prognostic significance of the 67-kiloDalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst. 1993;85:398-402.
40. Ménard S, Squicciarini P, Luini A, et al. Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumor prognostic features. Br J Cancer. 1994;69:1126-9.
41. Gasparini G, Barbareschi M, Boracchi P, et al. 67-Kda laminin-receptor expression adds prognostic information in intra-tumoral microvessel density in node-negative breast cancer. Int J Cancer. 1995;60:604-10.
42. Nadji M, Nassiri M, Fresno M, et al. Laminin Receptor in lymphnode negative breast carcinoma. Cancer. 1999;15:432-6.
43. Charpin C, Andrac L, Habib MC, et al. Correlation between laminin and type IV collagen distribution in breast carcinomas, and estrogen receptor expression, lymph node and vascular involvement. Med Oncol Tumor Pharmacother. 1990;7:43-54.
44. Heimann R, Hellman S. Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol. 2000;18:591-9.
45. Heimann R, Hellman S. Aging, progression, and phenotype in breast cancer. J Clin Oncol. 1998;16:2686-92.
46. Heimann R, Hellman S. Individual characterisation of the metastatic capacity of human breast carcinoma. Eur J Cancer. 2000; 36:1631-9.